Search results
Jump to navigation
Jump to search
Page title matches
- 2 KB (265 words) - 09:16, 28 December 2010
- 12 bytes (1 word) - 13:13, 10 November 2009
- 169 bytes (21 words) - 13:13, 10 November 2009
- 655 bytes (80 words) - 15:48, 11 January 2010
Page text matches
- ...ole in many cellular processes and [[inflammation]]. It is the target of [[Cyclooxygenase 2 inhibitor|cox2 inhibitors]]."<ref>{{MeSH}}</ref> Like cyclooxygenase 1 and lipoxygena [[Cyclooxygenase 2 inhibitor]]s are medications that block the action of cyclooxygenase 2.1 KB (145 words) - 03:04, 10 October 2010
- [[Cyclooxygenase 2 inhibitor]] are selective for [[cyclooxygenase-2]]. Most selective cyclooxygenase 22 KB (184 words) - 12:25, 28 December 2010
- #REDIRECT [[Cyclooxygenase 2 inhibitor]]40 bytes (3 words) - 13:13, 10 November 2009
- #redirect [[Cyclooxygenase 2 inhibitor]]40 bytes (3 words) - 13:15, 10 November 2009
- {{r|Cyclooxygenase 2 inhibitor}}406 bytes (43 words) - 13:40, 28 December 2010
- #REDIRECT [[Cyclooxygenase 2 inhibitor/Definition]]51 bytes (4 words) - 13:13, 10 November 2009
- #REDIRECT [[Cyclooxygenase 2 inhibitor/Approval]]49 bytes (4 words) - 13:13, 10 November 2009
- #REDIRECT [[Cyclooxygenase 2 inhibitor/Related Articles]]57 bytes (5 words) - 13:13, 10 November 2009
- * The relationship between [[colorectal cancer]] and [[cyclooxygenase 2 inhibitor]]s.<ref name="pmid17522398">{{cite journal| author=Chan AT, Ogino S, Fuchs1 KB (194 words) - 13:17, 2 February 2023
- '''Rofecoxib''' is a [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drug used as an analgesic until it was voluntarily withdrawn from the mar2 KB (331 words) - 10:20, 25 May 2010
- ...found specialists were more likely to adopt [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drugs before the drug [[rofecoxib]] was withdrawn by its manufacturers be25 KB (3,536 words) - 05:23, 25 November 2020
- ...rs of [[cyclooxygenase]] ([[non-steroidal anti-inflammatory agent]]s) or [[cyclooxygenase 2 inhibitor]]s.<ref name="pmid21149752">{{cite journal| author=Solomon DH, Rassen JA, G42 KB (5,794 words) - 14:08, 2 February 2023
- ...found specialists were more likely to adopt [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drugs before the drug [[rofecoxib]] was withdrawn by its manufacturers be55 KB (7,444 words) - 06:21, 29 August 2013
- ...found specialists were more likely to adopt [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drugs before the drug [[rofecoxib]] was withdrawn by its manufacturers be63 KB (8,790 words) - 06:57, 2 March 2021